First National Trust CO Boston Scientific Corp Transaction History

First National Trust CO

$2.44 Billion
Q1 2024

A detailed history of First National Trust CO transactions in Boston Scientific Corp stock. As of the latest transaction made, First National Trust CO holds 133,037 shares of BSX stock, worth $10.2 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

133,037

Previous 233,299 42.98%

Holding current value

$10.2 Million

Previous $13.5 Million 32.45%

% of portfolio

0.37%

Previous 0.6%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	SELL	$57.6 - $68.62 $5.78 Million - $6.88 Million	-100,262 Reduced 42.98%	133,037 $9.11 Million
Q4 2023 Feb 06, 2024	SELL	$48.64 - $57.81 $1.45 Million - $1.72 Million	-29,779 Reduced 11.32%	233,299 $13.5 Million
Q3 2023 Nov 06, 2023	BUY	$50.19 - $54.68 $383,702 - $418,028	7,645 Added 2.99%	263,078 $13.9 Million
Q2 2023 Aug 01, 2023	BUY	$49.72 - $54.64 $253,124 - $278,172	5,091 Added 2.03%	255,433 $13.8 Million
Q1 2023 Apr 26, 2023	SELL	$45.09 - $50.03 $16,052 - $17,810	-356 Reduced 0.14%	250,342 $12.5 Million

Q4 2022 Feb 02, 2023	BUY	$39.56 - $47.22 $209,826 - $250,454	5,304 Added 2.16%	250,698 $11.6 Million
Q3 2022 Nov 02, 2022	BUY	$36.71 - $109.66 $421,210 - $1.26 Million	11,474 Added 4.91%	245,394 $9.51 Million
Q2 2022 Aug 03, 2022	BUY	$35.24 - $47.1 $621,598 - $830,796	17,639 Added 8.16%	233,920 $8.72 Million
Q1 2022 May 03, 2022	BUY	$40.9 - $45.1 $1.35 Million - $1.49 Million	33,081 Added 18.06%	216,281 $9.58 Million
Q4 2021 Feb 03, 2022	BUY	$38.07 - $44.87 $6.97 Million - $8.22 Million	183,200 New	183,200 $7.78 Million

Others Institutions Holding BSX

# of Institutions

1,323

Shares Held

1.17B

Call Options Held

5.92M

Put Options Held

5.75M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $109B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First National Trust CO with notifications on news.

Account

First National Trust CO Boston Scientific Corp Transaction History